Bromocriptine treatment of tricyclic and heterocyclic antidepressant-resistant depression

Biological Psychiatry

Volumn 40, Issue 2, 1996, Pages 151-153

  Inoue, Takeshi ^a   Tsuchiya, Kiyoshi ^a   Miura, Jun ^a   Sakakibara, Satoshi ^a   Denda, Kenzo ^a   Kasahara, Toshihiko ^a   Koyama, Tsukasa ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

affective disorder; antidepressants; bromocriptine; dopamine; refractory depression; treatment resistant depression

Indexed keywords

AMOXAPINE; ANTIDEPRESSANT AGENT; BROMOCRIPTINE; CLOMIPRAMINE; IMIPRAMINE; THYROID HORMONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; FEMALE; HUMAN; MALE; MELANCHOLIA; PRIORITY JOURNAL;

EID: 0029954387     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00666-4     Document Type: Article

References (5)

1. Bouckoms A, Mangini L (1993): Pergolide: An antidepressant adjuvant for mood disorders? Psychopharmacol Bull 29:207-211.
2. Bouras N, Bridges PK (1982): Bromocriptine in depression. Curr Med Res Opin 8:150-153.
3. Carboni E, Tanda GL, Frau R, Di Chiara G (1990): Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: Evidence that dopamine is taken up in vivo by noradrenergic terminals. J Neurochem 55:1067-1070.
4. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
5. Jackson DM, Jenkins OF, Ross SB (1988): The motor effects